IBD Stock Of The Day: Why Eli Lilly Is Outplaying Its Pharma Giant Peers

IBD Stock Of The Day: Why Eli Lilly Is Outplaying Its Pharma Giant Peers

Eli Lilly is the IBD Stock Of The Day after the pharma giant reaffirmed 2020 targets for solid earnings growth. Now, LLY stock is eyeing a breakout.